Bayer G4A Startup Accelerator - In 2018, our groundbreaking advances in device-based therapeutic stroke rehabilitation technology garnered the recognition of Bayer Pharmaceuticals’ G4A Startup Accelerator program. Out of a pool of 1800+ medical technology startups, KinAptic was selected as one of six companies to join Bayer in Berlin, DE to receive funding and strategic support in our ongoing research and development. This relationship allows us to refine the therapeutic applications of our KinAptic Reactive Sleeve technology, and to develop novel clinical approaches in conjunction with Bayer’s global portfolio of medicines.
Link to Bayer Press Release
KinAptic Digital Therapeutics –
Wearable electronics with embedded AI advancing digital healthcare.
KinAptic uses our combined decades of experience in the fields of healthcare, medtech, and engineering to take novel human-machine interface products from concept to product.
Healthcare: Stroke rehabilitation, cardiovascular recovery, tremor mitigation, pain mitigation, diabetes remediation, biomarker and biometric detection.
Virtual and Augmented Reality: True haptic awareness, virtual object interactive physics.